🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This multi-site, Phase 1/2 clinical trial is an open-label study to identif...
Status
Recruiting
Location
Precision NextGen Oncology
Start Date
2023-11-01
Trial ID
NCT06047379
The study will be conducted in compliance with the International Council fo...
Status
Completed
Location
Local Institution - 338
Start Date
2019-05-20
Trial ID
NCT03900715
Treatments Being Tested
This clinical trial is carried out in two phases. The first phase adopts an...
Status
Unknown
Location
Hunan Provincial Center for Disease Control and Prevention
Start Date
2021-04-10
Trial ID
NCT04852068
Treatments Being Tested
The study hypothesis is that erythropoietin usage after kidney transplantat...
Status
Unknown
Location
Multiple Locations
Start Date
2008-03
Trial ID
NCT00617474
Treatments Being Tested
VG161 is a recombinant human-IL12/15/PDL1B oncolytic HSV-1 Injectable. This...
Status
Unknown
Location
the First Affiliated Hospital, School of Medicine, Zhejiang University
Start Date
2022-03-08
Trial ID
NCT05162118
This study will test whether vaccination with viagenpumatucel-L combined wi...
Status
Completed
Location
University of Arizona Cancer Center
Start Date
2015-04-15
Trial ID
NCT02439450
Treatments Being Tested
This is a phase I, interventional, single-arm, open-label, dose-finding tre...
Status
Recruiting
Location
Froedtert & the Medical College of Wisconsin
Start Date
2026-05-15
Trial ID
NCT05976555
RATIONALE: Bortezomib may stop the growth of myeloma cells by blocking prot...
Status
Unknown
Location
The Second Affiliated Hospital of Soochow University
Start Date
2013-12
Trial ID
NCT02027220
Treatments Being Tested
This study has 2 parts. The main aim of Part 1 is to check for side effect...
Status
Active Not Recruiting
Location
University of Alabama at Birmingham
Start Date
2021-11-12
Trial ID
NCT05020015
Treatments Being Tested
IP: RD07 cell injection; Target disease：solid tumor; Protocol design： Singl...
Status
Unknown
Location
Multiple Locations
Start Date
2022-04-01
Trial ID
NCT05284968
Treatments Being Tested